The North America Non-Hodgkins Lymphoma and Chronic Lymphoma Treatment Market is witnessing steady growth, supported by the region's advanced healthcare infrastructure, increasing prevalence of hematologic cancers, and widespread adoption of targeted therapies and immunotherapies. Strong investments in oncology research, favorable reimbursement policies, and the presence of...